STUDY SEARCH RESULTS

1 study found for your search request:  0616-015

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORA...
Condition: Arteriosclerosis, Hypercholesterolaemia
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06008756
Status: Active, not recruiting




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site